Tally Health

What it is

Tally Health is a direct-to-consumer longevity brand co-founded with David Sinclair’s involvement. The flagship product is TallyAge, an epigenetic-age test from a cheek swab, paired with lifestyle recommendations and a supplement line.

What the test measures

TallyAge is a methylation-based clock trained on cheek-swab samples. Like other epigenetic clocks, it estimates biological age and tracks change over time. Cheek-swab clocks are operationally simpler than blood-based clocks but the precision and intervention-responsiveness of any individual commercial clock should be treated cautiously.

How to evaluate direct-to-consumer biological-age products

• Test–retest reproducibility: single readings are noisy. Trend over multiple time-points is more informative than any single number.
• Reported “age reductions” from short interventions are often within measurement noise.
• Supplement bundles sold alongside biological-age tests should be evaluated on their own evidence, not on the implied promise of the test.
• Conflict of interest: most companies in this space sell both the measurement and the recommended intervention.

Why it’s covered here

Tally is one example of a much larger direct-to-consumer category. The brand-level details matter less than the general framework: be sceptical of bundled measure-and-treat offerings, prefer interventions with independent evidence, and use biological-age tests as a longitudinal research tool rather than a diagnostic.

Related entries

See also: Epigenetic clocks, David Sinclair, NAD+ precursors.